Liquid biopsy study for advanced cancers ends early
NCT ID NCT06290856
First seen Feb 01, 2026 · Last updated May 22, 2026 · Updated 13 times
Summary
This study aimed to see if blood-based DNA tests (liquid biopsies) could help doctors make better treatment decisions for people with advanced colorectal, pancreatic, or bile duct cancer. Researchers planned to enroll about 16 participants to check if these tests change how patients are diagnosed or treated. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Oslo university Hospital
Oslo, Norway
Conditions
Explore the condition pages connected to this study.